PDE5A and lung carcinoma: Several studies have shown that PDE5 expression is increased in multiple human carcinomas including metastatic breast cancers, colon adenocarcinoma, bladder squamous carcinoma, and lung cancers as compared to adjacent normal tissues [1–6], suggesting its potential role in controlling tumor cell growth and death.